Royal Bank Of Canada Lowers Equifax (NYSE:EFX) Price Target to $222.00

Equifax (NYSE:EFX) had its price target dropped by Royal Bank Of Canada from $250.00 to $222.00 in a note issued to investors on Thursday, MarketBeat reports. The brokerage currently has an “outperform” rating on the credit services provider’s stock. Royal Bank Of Canada’s price target would suggest a potential upside of 18.84% from the company’s current price.

Several other brokerages have also weighed in on EFX. Robert W. Baird set a $250.00 price objective on shares of Equifax in a report on Thursday. Morgan Stanley dropped their target price on shares of Equifax from $269.00 to $244.00 and set an “overweight” rating for the company in a research report on Wednesday. Wells Fargo & Company reduced their price target on Equifax from $265.00 to $240.00 and set an “overweight” rating on the stock in a research report on Thursday. Needham & Company LLC decreased their price objective on Equifax from $295.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday. Finally, Stifel Nicolaus cut their target price on Equifax from $295.00 to $253.00 and set a “buy” rating on the stock in a research note on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $245.64.

Equifax Trading Up 3.2%

Shares of EFX traded up $5.76 during trading hours on Thursday, hitting $186.80. 1,934,936 shares of the stock traded hands, compared to its average volume of 1,980,369. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.82. Equifax has a 1-year low of $166.02 and a 1-year high of $281.03. The firm has a market capitalization of $22.86 billion, a PE ratio of 35.55, a price-to-earnings-growth ratio of 1.78 and a beta of 1.55. The business has a fifty day moving average of $213.55 and a 200-day moving average of $228.29.

Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, February 4th. The credit services provider reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.05 by $0.04. Equifax had a return on equity of 19.28% and a net margin of 11.08%.The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period last year, the company earned $2.12 earnings per share. The company’s revenue was up 9.3% on a year-over-year basis. Equifax has set its FY 2026 guidance at 8.300-8.700 EPS and its Q1 2026 guidance at 1.630-1.730 EPS. Analysts expect that Equifax will post 7.58 EPS for the current year.

Institutional Investors Weigh In On Equifax

Several large investors have recently made changes to their positions in the stock. Accretive Wealth Partners LLC boosted its stake in Equifax by 1.1% in the 2nd quarter. Accretive Wealth Partners LLC now owns 4,564 shares of the credit services provider’s stock worth $1,184,000 after purchasing an additional 48 shares during the period. Cary Street Partners Investment Advisory LLC lifted its holdings in shares of Equifax by 12.5% in the third quarter. Cary Street Partners Investment Advisory LLC now owns 458 shares of the credit services provider’s stock valued at $117,000 after purchasing an additional 51 shares in the last quarter. HighPoint Advisor Group LLC boosted its position in shares of Equifax by 2.8% during the third quarter. HighPoint Advisor Group LLC now owns 1,971 shares of the credit services provider’s stock worth $506,000 after buying an additional 53 shares during the period. Heritage Family Offices LLP grew its holdings in shares of Equifax by 2.8% during the third quarter. Heritage Family Offices LLP now owns 2,126 shares of the credit services provider’s stock worth $545,000 after buying an additional 57 shares in the last quarter. Finally, Brighton Jones LLC raised its position in Equifax by 1.6% in the 2nd quarter. Brighton Jones LLC now owns 3,723 shares of the credit services provider’s stock valued at $966,000 after buying an additional 58 shares during the last quarter. Institutional investors own 96.20% of the company’s stock.

Key Headlines Impacting Equifax

Here are the key news stories impacting Equifax this week:

• Positive Sentiment: Q4 beat on both EPS and revenue; fourth-quarter revenue grew ~9% and topped guidance, which supports the stock’s upside narrative. Equifax Q4 press release / slide deck
• Positive Sentiment: Management highlighted VantageScore traction and targeted stronger growth in 2026 — a potential longer-term revenue driver if adoption continues. Equifax sees VantageScore traction
• Positive Sentiment: Company cited AI and cloud-driven product innovation and efficiency gains (90%+ revenue on Equifax Cloud), which supports margin expansion and new product monetization over time. Equifax: AI tools drive product innovation
• Positive Sentiment: Strategic partnership expansion (Gen and Equifax) to deliver broader consumer financial solutions could open cross‑sell and data‑services opportunities. Gen and Equifax partnership
• Neutral Sentiment: Some analysts trimmed price targets but kept buy ratings (e.g., Needham lowered its PT to $265 while maintaining a buy), signaling continued analyst support though with reduced upside. Needham lowers price target
• Neutral Sentiment: Full‑year 2026 EPS guidance was given (EPS range roughly in line with consensus), which offers some visibility for the year but leaves near‑term sensitivity to execution. Reuters: Equifax projects 2026 profit
• Negative Sentiment: Q1 2026 EPS guidance came in below Street estimates, prompting caution for the near term and explaining some analyst downward revisions. Zacks: Q4 beat but cautious Q1 outlook
• Negative Sentiment: Multiple analysts cut forecasts after the quarter (broader PT trimming), which reduces near‑term analyst-driven upside. Benzinga: Analysts cut forecasts after Q4
• Negative Sentiment: Political/regulatory risk: Senators have publicly accused Equifax of “price‑gouging” related to Medicaid programs, a reputational and regulatory overhang that could pressure the stock if it escalates. NYT: Senators accuse Equifax of price‑gouging

Equifax Company Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.